Immune Cells Derived from Stem Cells May Reverse Age-Related Brain Changes and Alzheimer’s Signs
New research shows that youthful immune cells derived from stem cells can reverse signs of brain aging and improve memory in mouse models, promising potential therapies for neurodegenerative diseases.
Researchers at Cedars-Sinai Medical Center have discovered that 'young' immune cells, generated from human stem cells, can reverse signs of aging and neurodegeneration in the brains of laboratory mice. Published in the journal Advanced Science, this preclinical study highlights the potential of harnessing immune cell therapy to combat cognitive decline associated with aging and Alzheimer's disease.
The study focused on mononuclear phagocytes—immune cells responsible for clearing harmful substances from the body, which typically decline in effectiveness with age. Scientists used pluripotent stem cells, which are adult cells reverted to an early embryonic state, to produce youthful versions of these immune cells. When infused into aging mice or models of Alzheimer’s, these cells produced notable improvements.
Mice treated with these young immune cells demonstrated better memory performance in behavioral tests and showed increased numbers of mossy cells in the hippocampus—a critical region for learning and memory. Additionally, the microglia, which act as the brain’s resident immune cells, remained healthier with more extensive branching, indicating preserved function.
Interestingly, the young immune cells did not appear to directly enter the brain, suggesting their beneficial effects might be mediated through indirect mechanisms, such as releasing protective proteins or extracellular vesicles into the bloodstream that influence brain health.
This research opens the door for developing personalized immune cell therapies from stem cells, offering an unlimited source of treatment candidates. The findings suggest that short-term interventions with these cells could significantly improve cognition and neural health, paving the way for future clinical trials in humans.
The study's authors believe that such therapies could provide promising new strategies for addressing age-related cognitive decline and neurodegenerative diseases like Alzheimer’s, by restoring immune function and brain health.
For more details, see the original publication in Advanced Science: DOI: 10.1002/advs.202417848.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Approach to Boost Brain Immunity Against HSV-1 by Targeting Viral Enzymes
Researchers at the University of Tokyo have developed a novel gene therapy targeting viral enzymes to reactivate the brain's natural immune defenses against HSV-1, opening new doors in treating deadly brain infections.
Enhancing Brain-Computer Interface Learning with Mild Spinal Stimulation
A new study shows that mild spinal stimulation can cut brain-computer interface training time in half, opening new avenues for motor rehabilitation and assistive technology.
Innovative Toolkit Developed by Researchers to Combat Brain Disorders
Discover how researchers from UC Irvine have developed advanced AAV vector tools to target specific brain cells, opening new pathways for treating neurological disorders like Alzheimer's and stroke.
Research Reveals Gaps in Health Monitoring for Children on Antipsychotic Medications
A new study finds that children prescribed antipsychotics in Australia receive inadequate health monitoring, raising concerns about metabolic and hormonal risks during critical developmental periods. Improved systemic checks are urgently needed.